{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:10:33Z","timestamp":1784769033940,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.intimp.2022.109481","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T01:25:40Z","timestamp":1670289940000},"page":"109481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The effects of taraxasterol on liver fibrosis revealed by RNA sequencing"],"prefix":"10.1016","volume":"114","author":[{"given":"Haiyan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruobing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houkang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2022.109481_b0005","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.32163","article-title":"Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases","volume":"75","author":"Gin\u00e8s","year":"2022","journal-title":"Hepatology (Baltimore, MD)"},{"key":"10.1016\/j.intimp.2022.109481_b0010","doi-asserted-by":"crossref","unstructured":"X.J. Ye, R. Xu, S.Y. Liu, B. Hu, Z.J. Shi, F.L. Shi, et al., Taraxasterol mitigates Con A-induced hepatitis in mice by suppressing interleukin-2 expression and its signaling in T lymphocytes, International immunopharmacology. 102(2022) 108380, https:\/\/doi.org\/10.1016\/j.intimp.2021.108380.","DOI":"10.1016\/j.intimp.2021.108380"},{"issue":"1","key":"10.1016\/j.intimp.2022.109481_b0015","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1080\/21691401.2019.1671433","article-title":"Taraxasterol from Taraxacum prevents concanavalin A-induced acute hepatic injury in mice via modulating TLRs\/NF-\u03baB and Bax\/Bc1-2 signalling pathways","volume":"47","author":"Sang","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"7","key":"10.1016\/j.intimp.2022.109481_b0020","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00109-018-1652-7","article-title":"Taraxasterol suppresses the growth of human liver cancer by upregulating Hint1 expression","volume":"96","author":"Bao","year":"2018","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.intimp.2022.109481_b0025","doi-asserted-by":"crossref","first-page":"118546","DOI":"10.1016\/j.lfs.2020.118546","article-title":"Effects of taraxasterol against ethanol and high-fat diet-induced liver injury by regulating TLR4\/MyD88\/NF-\u03baB and Nrf2\/HO-1 signaling pathways","volume":"262","author":"Li","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2022.109481_b0030","doi-asserted-by":"crossref","first-page":"113422","DOI":"10.1016\/j.jep.2020.113422","article-title":"The effects of Gentiana dahurica Fisch on alcoholic liver disease revealed by RNA sequencing","volume":"279","author":"Cao","year":"2021","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109481_b0035","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2020.08.033","article-title":"Endothelial GATA4 controls liver fibrosis and regeneration by preventing a pathogenic switch in angiocrine signaling","volume":"74","author":"Winkler","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2022.109481_b0040","article-title":"Scoparone alleviates hepatic fibrosis by inhibiting the TLR-4\/NF-\u03baB pathway","author":"Gao","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2022.109481_b0045","doi-asserted-by":"crossref","first-page":"105765","DOI":"10.1016\/j.intimp.2019.105765","article-title":"Research progress on the anti-hepatic fibrosis action and mechanism of natural products","volume":"75","author":"Shan","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2022.109481_b0050","doi-asserted-by":"crossref","first-page":"6397","DOI":"10.1111\/jcmm.15286","article-title":"Polysaccharides from Dicliptera chinensis ameliorate liver disturbance by regulating TLR-4\/NF-\u03baB and AMPK\/Nrf2 signalling pathways","volume":"24","author":"Zhang","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.intimp.2022.109481_b0055","doi-asserted-by":"crossref","unstructured":"K. Zhang, Y. Gao, M. Zhong, Y. Xu, J. Li, Y. Chen, et al., Hepatoprotective effects of Dicliptera chinensis polysaccharides on dimethylnitrosamine-induced hepatic fibrosis rats and its underlying mechanism, Journal of ethnopharmacology. 179(2016) 38-44, https:\/\/ doi.org\/10.1016\/j.jep.2015.12.053.","DOI":"10.1016\/j.jep.2015.12.053"},{"issue":"8","key":"10.1016\/j.intimp.2022.109481_b0060","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.3390\/ijms23084429","article-title":"S-Acetyl-Glutathione Attenuates Carbon Tetrachloride-Induced Liver Injury by Modulating Oxidative Imbalance and Inflammation","volume":"23","author":"Di Paola","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"10.1016\/j.intimp.2022.109481_b0065","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1039\/D1BM01499D","article-title":"Resolving hepatic fibrosis via suppressing oxidative stress and an inflammatory response using a novel hyaluronic acid modified nanocomplex","volume":"9","author":"Ren","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.intimp.2022.109481_b0070","doi-asserted-by":"crossref","unstructured":"S. Dupont, L. Morsut, M. Aragona, E. Enzo, S. Giulitti, M. Cordenonsi, et al., Role of YAP\/TAZ in mechanotransduction, Nature. 474(7350)(2011) 179-183, https:\/\/doi.org\/10. 1038\/ nature10137.","DOI":"10.1038\/nature10137"},{"issue":"8","key":"10.1016\/j.intimp.2022.109481_b0075","first-page":"1065","article-title":"Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases, Liver international : official journal of the International Association for the Study of the","volume":"28","author":"Gressner","year":"2008","journal-title":"Liver"},{"issue":"1","key":"10.1016\/j.intimp.2022.109481_b0080","doi-asserted-by":"crossref","first-page":"21018","DOI":"10.1038\/s41598-020-78056-0","article-title":"Proline-rich tyrosine kinase 2 mediates transforming growth factor-beta-induced hepatic stellate cell activation and liver fibrosis","volume":"10","author":"Kim","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2022.109481_b0085","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jhep.2015.04.011","article-title":"The Hippo pathway effector YAP controls mouse hepatic stellate cell activation","volume":"63","author":"Mannaerts","year":"2015","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.intimp.2022.109481_b0090","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1038\/s41401-021-00754-w","article-title":"Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation","volume":"42","author":"Lu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2022.109481_b0095","doi-asserted-by":"crossref","unstructured":"X. Jiang, J. Hu, Z. Wu, S.T. Cafarello, M. Di Matteo, Y. Shen, et al., Protein Phosphatase 2A Mediates YAP Activation in Endothelial Cells Upon VEGF Stimulation and Matrix Stiffness, Frontiers in cell and developmental biology. 9(2021) 675562-675576, https:\/\/doi.org\/10. 3389\/fcell.2021.675562.","DOI":"10.3389\/fcell.2021.675562"},{"issue":"1","key":"10.1016\/j.intimp.2022.109481_b0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.15252\/embr.201642683","article-title":"Phosphorylation by NLK inhibits YAP-14-3-3-interactions and induces its nuclear localization","volume":"18","author":"Moon","year":"2017","journal-title":"EMBO Rep."},{"key":"10.1016\/j.intimp.2022.109481_b0105","doi-asserted-by":"crossref","unstructured":"B.L. Copple, S. Kaska, C. Wentling, Hypoxia-inducible factor activation in myeloid cells contributes to the development of liver fibrosis in cholestatic mice, The Journal of pharmacology and experimental therapeutics. 341(2)(2012) 307-316, https:\/\/doi.org\/ 10.1124\/ jpet.111.189340.","DOI":"10.1124\/jpet.111.189340"},{"issue":"40","key":"10.1016\/j.intimp.2022.109481_b0110","doi-asserted-by":"crossref","first-page":"14841","DOI":"10.3748\/wjg.v20.i40.14841","article-title":"Gut-liver axis improves with meloxicam treatment after cirrhotic liver resection","volume":"20","author":"Hamza","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109481_b0115","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","article-title":"HIF-1\u03b1 pathway: role, regulation and intervention for cancer therapy","volume":"5","author":"Masoud","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"issue":"2020","key":"10.1016\/j.intimp.2022.109481_b0120","first-page":"113870","article-title":"Deltamethrin induces liver fibrosis in quails via activation of the TGF-\u03b21\/Smad signaling pathway","volume":"259","author":"Han","year":"1987","journal-title":"Environmental pollution (Barking Essex)"},{"issue":"3","key":"10.1016\/j.intimp.2022.109481_b0125","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/jcmm.16267","article-title":"PPAR\u03b3\/NF-\u03baB and TGF-\u03b21\/Smad pathway are involved in the anti-fibrotic effects of levo-tetrahydropalmatine on liver fibrosis","volume":"25","author":"Yu","year":"2021","journal-title":"J. Cell Mol. Med."},{"issue":"11","key":"10.1016\/j.intimp.2022.109481_b0130","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1111\/bph.15289","article-title":"Regulation of hepatic stellate cell contraction and cirrhotic portal hypertension by Wnt\/\u03b2-catenin signalling via interaction with Gli1","volume":"178","author":"Zhang","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109481_b0135","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13287-019-1204-2","article-title":"Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt\/\u03b2-catenin pathway","volume":"10","author":"Rong","year":"2019","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.intimp.2022.109481_b0140","doi-asserted-by":"crossref","first-page":"G39","DOI":"10.1152\/ajpgi.00263.2007","article-title":"Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis","volume":"294","author":"Cheng","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109481_b0145","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ptr.6824","article-title":"Apoptotic and antihepatofibrotic effect of honokiol via activation of GSK3\u03b2 and suppression of Wnt\/\u03b2-catenin pathway in hepatic stellate cells","volume":"35","author":"Lee","year":"2021","journal-title":"Phytotherapy research : PTR."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922009663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922009663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:53:34Z","timestamp":1761587614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922009663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":29,"alternative-id":["S1567576922009663"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109481","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of taraxasterol on liver fibrosis revealed by RNA sequencing","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109481"}}